Steris (BSP:S1TE34) Pre-Tax Income : R$3,403 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Steris Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Steris's pretax income for the three months ended in Dec. 2023 was R$878 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was R$3,403 Mil. Steris's pretax margin was 12.85%.

During the past 13 years, Steris's highest Pretax Margin was 16.65%. The lowest was 3.17%. And the median was 11.45%.

Steris Pre-Tax Income Historical Data

The historical data trend for Steris's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Pre-Tax Income Chart

Steris Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Pre-Tax Income

Get a 7-Day Free Trial

1,417.33

2,437.01

2,916.35

1,565.09

819.56

Steris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															841.04	1,016.31	766.47	741.57	878.48

Competitive Comparison of Steris's Pre-Tax Income

For the Medical Devices subindustry, Steris's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steris's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Steris's Pre-Tax Income falls into.

Steris Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Steris's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	3954.551	+	-2557.683	+	-577.306	+	0	+	0.00100000000009
	=	820

Steris's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	1059.151	+	-0.029	+	-190.833	+	10.192	+	-0.00100000000009
	=	878

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$3,403 Mil.

Steris (BSP:S1TE34) Pre-Tax Income Explanation

Steris's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	878.48	/	6838.381
	=	12.85%

During the past 13 years, Steris's highest Pretax Margin was 16.65%. The lowest was 3.17%. And the median was 11.45%.

Steris Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Steris's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Steris (BSP:S1TE34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

STE:USA

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris-ir.com

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Steris (BSP:S1TE34) Headlines

No Headlines